MABT5102A

MABT5102A · Genentech, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for MABT5102A, covering 2010-10-27 to 2017-07-12. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY) [Phase 2]

See pricing